Cargando…
The Gut Microbiome in Anorexia Nervosa: Friend or Foe?
The human gut microbiome is emerging as a key modulator of homeostasis, with far-reaching implications for various multifactorial diseases, including anorexia nervosa (AN). Despite significant morbidity and mortality, the underlying mechanisms of this eating disorder are poorly understood, but the c...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835121/ https://www.ncbi.nlm.nih.gov/pubmed/33510660 http://dx.doi.org/10.3389/fpsyt.2020.611677 |
_version_ | 1783642445769080832 |
---|---|
author | Ghenciulescu, Ana Park, Rebecca J. Burnet, Philip W. J. |
author_facet | Ghenciulescu, Ana Park, Rebecca J. Burnet, Philip W. J. |
author_sort | Ghenciulescu, Ana |
collection | PubMed |
description | The human gut microbiome is emerging as a key modulator of homeostasis, with far-reaching implications for various multifactorial diseases, including anorexia nervosa (AN). Despite significant morbidity and mortality, the underlying mechanisms of this eating disorder are poorly understood, but the classical view defining AN as a purely psychiatric condition is increasingly being challenged. Accumulating evidence from comparative studies of AN and healthy fecal microbial composition reveals considerable low divergence and altered taxonomic abundance of the AN gut microbiome. When integrated with preclinical data, these findings point to a significant role of the gut microbiome in AN pathophysiology, via effects on host energy metabolism, intestinal permeability, immune function, appetite, and behavior. While complex causal relationships between genetic risk factors, dietary patterns and microbiome, and their relevance for AN onset and perpetuation have not been fully elucidated, preliminary clinical studies support the use of microbiome-based interventions such as fecal microbiota transplants and probiotics as adjuvants to standard AN therapies. Future research should aim to move from observational to mechanistic, as dissecting how specific microbial taxa interact with the host to impact the development of AN could help design novel therapeutic approaches that more effectively address the severe comorbidities and high relapse rate of this serious disorder. |
format | Online Article Text |
id | pubmed-7835121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78351212021-01-27 The Gut Microbiome in Anorexia Nervosa: Friend or Foe? Ghenciulescu, Ana Park, Rebecca J. Burnet, Philip W. J. Front Psychiatry Psychiatry The human gut microbiome is emerging as a key modulator of homeostasis, with far-reaching implications for various multifactorial diseases, including anorexia nervosa (AN). Despite significant morbidity and mortality, the underlying mechanisms of this eating disorder are poorly understood, but the classical view defining AN as a purely psychiatric condition is increasingly being challenged. Accumulating evidence from comparative studies of AN and healthy fecal microbial composition reveals considerable low divergence and altered taxonomic abundance of the AN gut microbiome. When integrated with preclinical data, these findings point to a significant role of the gut microbiome in AN pathophysiology, via effects on host energy metabolism, intestinal permeability, immune function, appetite, and behavior. While complex causal relationships between genetic risk factors, dietary patterns and microbiome, and their relevance for AN onset and perpetuation have not been fully elucidated, preliminary clinical studies support the use of microbiome-based interventions such as fecal microbiota transplants and probiotics as adjuvants to standard AN therapies. Future research should aim to move from observational to mechanistic, as dissecting how specific microbial taxa interact with the host to impact the development of AN could help design novel therapeutic approaches that more effectively address the severe comorbidities and high relapse rate of this serious disorder. Frontiers Media S.A. 2021-01-12 /pmc/articles/PMC7835121/ /pubmed/33510660 http://dx.doi.org/10.3389/fpsyt.2020.611677 Text en Copyright © 2021 Ghenciulescu, Park and Burnet. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Ghenciulescu, Ana Park, Rebecca J. Burnet, Philip W. J. The Gut Microbiome in Anorexia Nervosa: Friend or Foe? |
title | The Gut Microbiome in Anorexia Nervosa: Friend or Foe? |
title_full | The Gut Microbiome in Anorexia Nervosa: Friend or Foe? |
title_fullStr | The Gut Microbiome in Anorexia Nervosa: Friend or Foe? |
title_full_unstemmed | The Gut Microbiome in Anorexia Nervosa: Friend or Foe? |
title_short | The Gut Microbiome in Anorexia Nervosa: Friend or Foe? |
title_sort | gut microbiome in anorexia nervosa: friend or foe? |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835121/ https://www.ncbi.nlm.nih.gov/pubmed/33510660 http://dx.doi.org/10.3389/fpsyt.2020.611677 |
work_keys_str_mv | AT ghenciulescuana thegutmicrobiomeinanorexianervosafriendorfoe AT parkrebeccaj thegutmicrobiomeinanorexianervosafriendorfoe AT burnetphilipwj thegutmicrobiomeinanorexianervosafriendorfoe AT ghenciulescuana gutmicrobiomeinanorexianervosafriendorfoe AT parkrebeccaj gutmicrobiomeinanorexianervosafriendorfoe AT burnetphilipwj gutmicrobiomeinanorexianervosafriendorfoe |